Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone and nebulised adrenaline for severe bronchiolitis in intensive care
ACTRN12613000316707Phase 3Terminated
- Sponsor
- The Royal Children's Hospital
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of dexamethasone, epinephrine, prednisolone and methylprednisolone in bronchiolitis (2 arms), sponsored by The Royal Children's Hospital. Primary endpoint: Duration of non-invasive or invasive positive pressure support. Started Jul 2013; status: terminated.
02
Drugs
dexamethasoneepinephrineprednisolonemethylprednisolone
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on ACTRN12613000316707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000316707.